Addison’s Disease: Diagnosis and Management Strategies

References

• Graves LE, Torpy DJ, Coates PT, Alexander IE, Bornstein SR, Clarke B. Future directions for adrenal insufficiency: cellular transplantation and genetic therapies. J Clin Endocrinol Metab. 2023;dgac751. doi:10.1210/clinem/dgac751
   Web of Science ®Google Scholar
• Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–389. doi:10.1210/jc.2015-1710
   PubMed Web of Science ®Google Scholar
• Almeida MQ. Genetic diagnosis of primary adrenal insufficiency in children: a paradigm change. J Endocr Soc. 2021;5(9):bvab117. doi:10.1210/jendso/bvab117
   PubMed Web of Science ®Google Scholar
• Miller WL, White PC. History of adrenal research: from ancient anatomy to contemporary molecular biology. Endocr Rev. 2023;44(1):70–116. doi:10.1210/endrev/bnac019
   PubMed Web of Science ®Google Scholar
• Irfan M, Iqbal T, Hashmi S, Ghani U, Bhatti A. Insilico prediction and functional analysis of nonsynonymous SNPs in human CTLA4 gene. Sci Rep. 2022;12(1):20441. doi:10.1038/s41598-022-24699-0
   PubMed Web of Science ®Google Scholar
• Røyrvik EC, Husebye ES. The genetics of autoimmune Addison disease: past, present and future. Nat Rev Endocrinol. 2022;18(7):399–412. doi:10.1038/s41574-022-00653-y
   PubMed Web of Science ®Google Scholar
• Nelson HA, Joshi HR, Straseski JA. Mistaken identity: the role of autoantibodies in endocrine disease. J Appl Lab Med. 2022;7(1):206–220. doi:10.1093/jalm/jfab128
   PubMedGoogle Scholar
• Alter DN. Commentary on an unusual presentation of autoimmune primary adrenal insufficiency. Clin Chem. 2022;68(11):1379. doi:10.1093/clinchem/hvac164
   PubMedGoogle Scholar
• Howarth S, Giovanelli L, Napier C, Pearce SH. Heterogeneous natural history of Addison’s disease: mineralocorticoid deficiency may predominate. Endocr Connect. 2022;12(1):e220305. doi:10.1530/EC-22-0305
   PubMed Web of Science ®Google Scholar
• Grabarczyk M, Gorczyca M, Cieślik P, Hrycek A, Holecki M. Addison’s disease in the course of recurrent microangiopathic antiphospholipid syndrome-a clinical presentation and review of the literature. Medicina. 2022;59(1):4. doi:10.3390/medicina59010004
   PubMedGoogle Scholar
• Giri S, Angadi S, Morupoju G, Bhrugumalla S. Intractable vomiting as a presentation of adrenal insufficiency - A case report. Trop Doct. 2023;53(1):179–180. doi:10.1177/00494755221122621
   PubMed Web of Science ®Google Scholar
• Momayez Sanat Z, Mohajeri-Tehrani MR. Psychotic disorder as the first manifestation of addison disease: a case report. Int J Endocrinol Metab. 2022;20(1):e121011. doi:10.5812/ijem.121011
   PubMed Web of Science ®Google Scholar
• Govind P, Subramanian K, Kumar S. Diagnostic and therapeutic implications of organic delusional disorder due to tuberculous adrenalitis. Case Rep Psychiatry. 2022;2022:5056976. doi:10.1155/2022/5056976
   PubMedGoogle Scholar
• Patel P, Kelschenbach K. Case of junctional rhythm in the setting of acute adrenal insufficiency. Cureus. 2022;14(8):e27605. doi:10.7759/cureus.27605
   PubMed Web of Science ®Google Scholar
• Amusina O, Mehta S, Nelson ME. Brugada phenocopy secondary to hyperkalemia and hyponatremia in primary adrenal insufficiency. J Am Coll Emerg Physicians Open. 2022;3(4):e12800. doi:10.1002/emp2.12800
   PubMedGoogle Scholar
• Ali N. Broad complex tachycardia, Addison’s disease, and ascending flacid paralysis: an interesting case on cardiology floor. J Coll Physicians Surg Pak. 2022;32(8):S98–S100. doi:10.29271/jcpsp.2022.Supp2.S98
   PubMedGoogle Scholar
• Page JW, Drinkwater J, Furniss G, Sahebjalal M. Cardiac tamponade as a presentation of primary adrenal insufficiency. BMJ Case Rep. 2022;15(3):e248099. doi:10.1136/bcr-2021-248099
   PubMedGoogle Scholar
• Glick LR, Hodson DZ, Sharma S, Savarimuthu S. Cardiac tamponade as the initial presentation of autoimmune polyglandular syndrome type 2: a case report. Eur Heart J Case Rep. 2022;6(5):ytac145. doi:10.1093/ehjcr/ytac145
   PubMedGoogle Scholar
• Somasundaram H, Boyer PN, Casey J, Wong M, Shenoy V. Primary adrenal lymphoma as a rare cause of primary adrenal insufficiency: challenges in management and a review of the literature. AACE Clin Case Rep. 2022;8(5):199–203. doi:10.1016/j.aace.2022.05.003
   PubMedGoogle Scholar
• Kuhn E, Sanchez JR, Shakir MK, Hoang TD. Primary adrenal insufficiency masking as an adrenal B-cell lymphoma. BMJ Case Rep. 2022;15(9):e250973. doi:10.1136/bcr-2022-250973
   PubMedGoogle Scholar
• Yousaf A, Tayyab A, Yasin ALF, et al. Bilateral primary adrenal B-cell lymphoma diagnosed by workup for primary adrenal deficiency. Gulf J Oncolog. 2022;1(39):92–96.
   PubMedGoogle Scholar
• Zhang Y, Zheng L, Ai Y, Luo M, Shi L, Zhang Q. Chinese primary adrenal lymphoma complicated with adrenal crisis: a case report and literature review. J Cancer Res Ther. 2022;18(5):1444–1448. doi:10.4103/jcrt.jcrt_878_22
   PubMed Web of Science ®Google Scholar
• Zeng J, Yan F, Chen Y, et al. Primary adrenal lymphoma: two case series from China. Front Endocrinol. 2022;12:778984. doi:10.3389/fendo.2021.778984
   PubMed Web of Science ®Google Scholar
• Yashar D, Govindarajan A, Samara Y, Lee J. A case of metastatic gastric leiomyosarcoma with bilateral adrenal involvement and complications. ACG Case Rep J. 2022;9(5):e00764. doi:10.14309/crj.0000000000000764
   PubMed Web of Science ®Google Scholar
• Alberti JF, Nardi WS, Recalde M, Quildrian SD. Bilateral adrenalectomy in the context of primary adrenal insufficiency due to colorectal cancer metastasis. Ecancermedicalscience. 2022;16:1395. doi:10.3332/ecancer.2022.1395
   PubMed Web of Science ®Google Scholar
• Shagjaa T, Sanga V, Rossi GP. Skin hyperpigmentation due to post-surgical adrenal insufficiency regressed with the dexamethasone treatment. J Clin Med. 2022;11(18):5379. doi:10.3390/jcm11185379
   PubMed Web of Science ®Google Scholar
• Aynaou H, Salhi H, El Ouahabi H. A case of acute adrenal insufficiency: a rare but possible cause of hypercalcemia. Cureus. 2022;14(5):e24752. doi:10.7759/cureus.24752
   PubMedGoogle Scholar
• Quigley N, Garneau AP, Haydock L, Isenring P. Extreme hyponatremia complicated by osmotic demyelination in a previously healthy young individual. Can J Kidney Health Dis. 2022;9:20543581221130686. doi:10.1177/20543581221130686
   Google Scholar
• Liu X, Xie Y, Tang J, Zhong J, Zeng D, Lan D. Aldosterone defects in infants and young children with hyperkalemia: a single center retrospective study. Front Pediatr. 2023;11:1092388. doi:10.3389/fped.2023.1092388
   PubMed Web of Science ®Google Scholar
• Ruiz-Sánchez JG, Calle-Pascual AL, Rubio-Herrera MÁ, De Miguel Novoa MP, Gómez-Hoyos E, Runkle I. Clinical manifestations and associated factors in acquired hypoaldosteronism in endocrinological practice. Front Endocrinol. 2022;13:990148. doi:10.3389/fendo.2022.990148
   PubMed Web of Science ®Google Scholar
• Chifu I, Weng AM, Burger-Stritt S, et al. Non-invasive assessment of tissue sodium content in patients with primary adrenal insufficiency. Eur J Endocrinol. 2022;187(3):383–390. doi:10.1530/EJE-22-0396
   PubMed Web of Science ®Google Scholar
• Zaric O, Beiglböck H, Janacova V, et al. Repeatability assessment of sodium (23Na) MRI at 7.0 T in healthy human calf muscle and preliminary results on tissue sodium concentrations in subjects with Addison’s disease. BMC Musculoskelet Disord. 2022;23(1):925. doi:10.1186/s12891-022-05879-5
   PubMed Web of Science ®Google Scholar
• Van’t Westeinde A, Padilla N, Siqueiros Sanchez M, et al. Brain structure in autoimmune Addison’s disease. Cereb Cortex. 2022;bhac389. doi:10.1093/cercor/bhac389
   Web of Science ®Google Scholar
• van der Gugten JG, Holmes DT. Quantitation of renin activity in plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Methods Mol Biol. 2022;2546:439–450. doi:10.1007/978-1-0716-2565-1_39
   PubMedGoogle Scholar
• Butt MI, Alzuhayri N, Riazuddin M, Bakhsh AMK. The short synacthen test: variations in methodology and protocols in. KSA J Taibah Univ Med Sci. 2022;17(4):596–601. doi:10.1016/j.jtumed.2022.01.010
   PubMed Web of Science ®Google Scholar
• Silva C, Patel TJ, Lam C. Diagnosis of adrenal insufficiency in children: a survey among pediatric endocrinologists in North America. J Pediatr Endocrinol Metab. 2022;36(2):195–198. doi:10.1515/jpem-2022-0444
   PubMed Web of Science ®Google Scholar
• Mancillas-Adame LG, Sánchez-García A, Rodriguez-Gutierrez R, et al. Low-dose ACTH stimulation test in obesity: a randomized dose assessment. Int J Endocrinol. 2022;2022:7860272. doi:10.1155/2022/7860272
   PubMed Web of Science ®Google Scholar
• Nisticò D, Bossini B, Benvenuto S, Pellegrin MC, Tornese G. Pediatric adrenal insufficiency: challenges and solutions. Ther Clin Risk Manag. 2022;18:47–60. doi:10.2147/TCRM.S294065
   PubMed Web of Science ®Google Scholar
• van der Gugten JG, Holmes DT. Quantitation of aldosterone in serum or plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Methods Mol Biol. 2022;(2546):45–54. doi:10.1007/978-1-0716-2565-1_5
   PubMedGoogle Scholar
• Mosca SM, Santos TS, Mendes ACB, et al. Pediatric adrenal insufficiency: thirty years’ experience at a Portuguese hospital. J Pediatr Endocrinol Metab. 2022;35(5):631–638. doi:10.1515/jpem-2021-0725
   PubMed Web of Science ®Google Scholar
• Le BT, Duong CM, Nguyen TQ, Nguyen CM. Two siblings with non-classic P450scc deficiency resulted from a novel mutation in CYP11A1 gene misdiagnosed as familial glucocorticoid deficiency. BMJ Case Rep. 2022;15(12):e250238. doi:10.1136/bcr-2022-250238
   PubMedGoogle Scholar
• Mellone S, Bertelli E, Roviglione B, et al. Co-occurrence of a pathogenic HSD3B2 variant and a duplication on 10q22.3-q23.2 detected in newborn twins with salt-wasting congenital adrenal hyperplasia. Genes. 2022;13(12):2190. doi:10.3390/genes13122190
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang T, Zhang L, et al. Clinical characteristics of a male child with non-classic lipoid congenital adrenal hyperplasia and literature review. Front Endocrinol. 2022;13:947762. doi:10.3389/fendo.2022.947762
   PubMed Web of Science ®Google Scholar
• Phadte A, Arya S, Sarathi V, et al. Side-chain cleavage enzyme deficiency: systematic review and case series. Clin Endocrinol. 2022;98:351–362. doi:10.1111/cen.14848
   PubMed Web of Science ®Google Scholar
• Ali N, Maharaj AV, Buonocore F, Achermann JC, Metherell LA. Can digenic, tri-allelic inheritance of variants in STAR and CYP11A1 give rise to primary adrenal insufficiency? A case report. Front Endocrinol. 2022;13:860055. doi:10.3389/fendo.2022.860055
   PubMed Web of Science ®Google Scholar
• Gupta P, Keller SR, Patterson B. Recurrent episodes of vomiting and diarrhoea in a male child: a rare presentation of X-linked adrenoleukodystrophy. BMJ Case Rep. 2022;15(8):e249905. doi:10.1136/bcr-2022-249905
   PubMedGoogle Scholar
• Wiersma RE, Gupta AO, Lund TC, et al. Primary adrenal insufficiency in a boy with type I diabetes: the importance of considering X-linked adrenoleukodystrophy. J Endocr Soc. 2022;6(5):bvac039. doi:10.1210/jendso/bvac039
   PubMed Web of Science ®Google Scholar
• Ghori M, Molani RA, Ibrahim PMN, Hanif MI, Jamal Raza J. X-linked adrenoleukodystrophy in a 20-year-old male with an ABCD1 gene mutation: first case from Pakistan. Cureus. 2022;14(2):e21837. doi:10.7759/cureus.21837
   PubMed Web of Science ®Google Scholar
• Dong B, Lv W, Xu L, et al. Identification of two novel mutations of ABCD1 gene in pedigrees with X-linked adrenoleukodystrophy and review of the literature. Int J Endocrinol. 2022;2022:5479781. doi:10.1155/2022/5479781
   PubMed Web of Science ®Google Scholar
• Chen HA, Hsu RH, Chen PW, et al. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan. Mol Genet Metab Rep. 2022;32:100902. doi:10.1016/j.ymgmr.2022.100902
   PubMed Web of Science ®Google Scholar
• Bonaventura E, Alberti L, Lucchi S, et al. Newborn screening for X-linked adrenoleukodystrophy in Italy: diagnostic algorithm and disease monitoring. Front Neurol. 2023;13:1072256. doi:10.3389/fneur.2022.1072256
   PubMed Web of Science ®Google Scholar
• Gagnon C, Hurst ACE, Ashraf AP. Adrenal insufficiency in peroxisomal disorders: a single institution case series. Horm Res Paediatr. 2023. doi:10.1159/000529126
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu Y, Gao K, Chen X. The etiology and clinical features of non-CAH primary adrenal insufficiency in children. Front Pediatr. 2022;10:961268. doi:10.3389/fped.2022.961268
   PubMed Web of Science ®Google Scholar
• Ron HA, Scobell R, Strong A, Salazar EG, Ganetzky R. Congenital adrenal calcifications as the first clinical indication of sphingosine lyase insufficiency syndrome: a case report and review of the literature. Am J Med Genet A. 2022;188(11):3312–3317. doi:10.1002/ajmg.a.62956
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu X, Xie X, He J, Gao Y. Adult-onset X-linked adrenal hypoplasia congenita caused by a novel mutation in DAX1/NR0B1: a case report and literature review. Exp Ther Med. 2022;24(4):628. doi:10.3892/etm.2022.11565
   PubMed Web of Science ®Google Scholar
• Ota T, Katsumata N, Naiki Y, Horikawa R. Novel non-stop variant of the NR0B1 gene in two siblings with adrenal hypoplasia congenita. J Pediatr Endocrinol Metab. 2022;35(9):1189–1193. doi:10.1515/jpem-2022-0120
   PubMed Web of Science ®Google Scholar
• Zhu F, Zhou M, Deng X, Li Y, Xiong J. Case report: a novel truncating variant of NR0B1 presented with X-linked late-onset adrenal hypoplasia congenita with hypogonadotropic hypogonadism. Front Endocrinol. 2022;13:897069. doi:10.3389/fendo.2022.897069
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen Q, Guo S, et al. Pleomorphism of the HPG axis with NR0B1 gene mutation - a case report of longitudinal follow-up of a proband with central precocious puberty. J Pediatr Endocrinol Metab. 2022;35(7):962–967. doi:10.1515/jpem-2021-0762
   PubMed Web of Science ®Google Scholar
• Tao N, Liu X, Chen Y, Sun M, Xu F, Su Y. Delayed diagnosis of complex glycerol kinase deficiency in a Chinese male infant: a case report. BMC Pediatr. 2022;22(1):517. doi:10.1186/s12887-022-03568-9
   PubMed Web of Science ®Google Scholar
• Sadeghmousavi S, Shahkarami S, Rayzan E, et al. A 3-year-old boy with an xp21 deletion syndrome: a case report. Endocr Metab Immune Disord Drug Targets. 2022;22(8):881–887. doi:10.2174/1871530322666220201143656
   PubMed Web of Science ®Google Scholar
• Tong Y, Yue D, Xin Y, Zhang D. GNAS mutation is an unusual cause of primary adrenal insufficiency: a case report. BMC Pediatr. 2022;22(1):472. doi:10.1186/s12887-022-03517-6
   PubMed Web of Science ®Google Scholar
• Dursun F, Genc HM, Mine Yılmaz A, et al. Primary adrenal insufficiency in a patient with biallelic QRSL1 mutations. Eur J Endocrinol. 2022;187(3):K27–K32. doi:10.1530/EJE-22-0233
   PubMed Web of Science ®Google Scholar
• Krasovec T, Sikonja J, Zerjav Tansek M, et al. Long-term follow-up of three family members with a novel NNT pathogenic variant causing primary adrenal insufficiency. Genes. 2022;13(5):717. doi:10.3390/genes13050717
   PubMed Web of Science ®Google Scholar
• Rivelli A, Fitzpatrick V, Wales D, et al. Prevalence of endocrine disorders among 6078 individuals with down syndrome in the United States. J Patient Cent Res Rev. 2022;9(1):70–74. doi:10.17294/2330-0698.1877
   PubMed Web of Science ®Google Scholar
• Seven Menevse T, Kendir Demirkol Y, Gurpinar Tosun B, et al. Steroid hormone profiles and molecular diagnostic tools in pediatric patients with non-CAH primary adrenal insufficiency. J Clin Endocrinol Metab. 2022;107(5):e1924–e1931. doi:10.1210/clinem/dgac016
   PubMed Web of Science ®Google Scholar
• Engelen M, van Ballegoij WJC, Mallack EJ, et al. International recommendations for the diagnosis and management of patients with adrenoleukodystrophy: a consensus-based approach. Neurology. 2022;99(21):940–951. doi:10.1212/WNL.0000000000201374
   PubMed Web of Science ®Google Scholar
• Pournasiri Z, Madani A, Nazarpack F, et al. Sphingosine phosphate lyase insufficiency syndrome: a systematic review. World J Pediatr. 2022;19:425–437. doi:10.1007/s12519-022-00615-4
   PubMed Web of Science ®Google Scholar
• Maharaj A, Kwong R, Williams J, et al. A retrospective analysis of endocrine disease in sphingosine-1-phosphate lyase insufficiency: case series and literature review. Endocr Connect. 2022;11(8):e220250. doi:10.1530/EC-22-0250
   PubMed Web of Science ®Google Scholar
• Giannakopoulos A, Sertedaki A, Efthymiadou A, Chrysis D. Addison’s disease without hyperpigmentation in pediatrics: pointing towards specific causes. Hormones. 2022;22:143–148. doi:10.1007/s42000-022-00415-5
   PubMedGoogle Scholar
• Batool W, Khan S, Naveed S, Ahmad SM. Disseminated tuberculosis presenting as cerebellar dysfunction and adrenal insufficiency in an immunocompetent patient: a rare coexistence. Cureus. 2022;14(10):e30551. doi:10.7759/cureus.30551
   PubMed Web of Science ®Google Scholar
• Khan Z, Jugnarain D, Mahamud B, Gupta A, Patel S, Mlawa G. Systemic manifestation of miliary tuberculosis in patient with advanced diabetic retinopathy presenting with electrolyte imbalance, seizures, and adrenal insufficiency. Cureus. 2022;14(1):e21047. doi:10.7759/cureus.21047
   PubMed Web of Science ®Google Scholar
• Kaneto H, Tatsumi F, Ohnishi M, et al. Addison’s disease triggered by infection with mycobacterium abscessus, but not by adrenal tuberculosis or MAC pulmonary disease, in a subject with type 2 diabetes mellitus: case report. BMC Endocr Disord. 2022;22(1):257. doi:10.1186/s12902-022-01178-1
   PubMed Web of Science ®Google Scholar
• Gunna S, Singh M, Pandey R, et al. Etiology, clinical characteristics and mortality among Indian patients with Addison’s disease. Endocr Connect. 2023:EC-22-0439. doi:10.1530/EC-22-0439
   PubMed Web of Science ®Google Scholar
• Sridhar S, Balachandran K, Nazirudeen R, Natarajan V, Sangumani J. Clinical profile of Addison’s disease in a tertiary care institute, Southern India - the changing landscape. Indian J Endocrinol Metab. 2022;26(1):50–54. doi:10.4103/ijem.ijem_164_21
   PubMedGoogle Scholar
• Pal N, Banu HN, Chakraborty M, Jain N, Maiti PK. Current perspective of adrenal histoplasmosis in India: a prospective study in a tertiary care hospital, Eastern India. Indian J Med Microbiol. 2022;43:S0255-0857(22)00190–6. doi:10.1016/j.ijmmb.2022.10.001
   PubMed Web of Science ®Google Scholar
• Agrawal SS, Chakraborty PP, Sinha A, Maiti A, Chakraborty M. Adrenal histoplasmosis: an eastern Indian perspective. Acta Endocrinol. 2022;18(1):106–114. doi:10.4183/aeb.2022.106
   Google Scholar
• Gasco V, Giannelli J, Campioni L, et al. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency. J Endocrinol Invest. 2022;46:587–597. doi:10.1007/s40618-022-01940-1
   PubMed Web of Science ®Google Scholar
• Ceccato F, Torchio M, Tizianel I, et al. Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency. J Endocrinol Invest. 2023;46(1):111–122. doi:10.1007/s40618-022-01889-1
   PubMed Web of Science ®Google Scholar
• Krutter S, Schuessler N, Kutschar P, et al. Piloting of the virtual telecare technology ‘Addison Care’ to promote self-management in persons with chronic diseases in a community setting: protocol for a mixed-methods user experience, user engagement and usability pilot study. BMJ Open. 2022;12(9):e062159. doi:10.1136/bmjopen-2022-062159
   PubMed Web of Science ®Google Scholar
• Westeinde AV, Ström S, Hirvikoski T, et al. Young adult Swedish patients with autoimmune Addison’s disease report difficulties with executive functions in daily life despite overall good cognitive performance. Psychoneuroendocrinology. 2022;140:105714. doi:10.1016/j.psyneuen.2022.105714
   PubMed Web of Science ®Google Scholar
• Blacha AK, Kropp P, Rahvar AH, Flitsch J, van de Loo I, Harbeck B. Poor quality of life and sleep in patients with adrenal insufficiency-another cause of increased mortality? Ir J Med Sci. 2022;191(4):1653–1658. doi:10.1007/s11845-021-02731-y
   PubMed Web of Science ®Google Scholar
• Li D, Brand S, Hamidi O, et al. Quality of life and its determinants in patients with adrenal insufficiency: a survey study at 3 centers in the United States. J Clin Endocrinol Metab. 2022;107(7):e2851–e2861. doi:10.1210/clinem/dgac175
   PubMed Web of Science ®Google Scholar
• Gaw AG, Wemyss C, Bell A, Goodall CA. Management of patients at risk of adrenal crisis in the dental setting: a review of current practice in UK dental teaching hospitals. Br Dent J. 2022. doi:10.1038/s41415-022-4515-0
   PubMed Web of Science ®Google Scholar
• Quinkler M, Kienitz T. The ISAQ score does not predict adrenal crisis in patients with primary adrenal insufficiency. Exp Clin Endocrinol Diabetes. 2022;130(8):554–560. doi:10.1055/a-1734-2466
   PubMedGoogle Scholar
• Sekhon SS, Crick K, Myroniuk TW, et al. Adrenal insufficiency: investigating prevalence and healthcare utilization using administrative data. J Endocr Soc. 2021;6(4):bvab184. doi:10.1210/jendso/bvab184
   PubMed Web of Science ®Google Scholar
• Zdrojowy-Wełna A, Halupczok-żyła J, Słoka N, Syrycka J, Gojny Ł, Bolanowski M. Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency. Front Endocrinol. 2022;13:996157. doi:10.3389/fendo.2022.996157
   PubMed Web of Science ®Google Scholar
• Guarnotta V, Di Stefano C, Giordano C. Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency. Sci Rep. 2022;12(1):13280. doi:10.1038/s41598-022-13506-5
   PubMed Web of Science ®Google Scholar
• Yazidi M, Danguir C, Maamer D, et al. Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency. Endocr Regul. 2022;56(3):209–215. doi:10.2478/enr-2022-0022
   PubMedGoogle Scholar
• Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733–743. doi:10.1016/S0140-6736(22)01349-6
   PubMed Web of Science ®Google Scholar
• Jamal H, LaLoggia M, Harjai N. Autoimmune polyglandular syndrome type II: a case report. Cureus. 2022;14(11):e31641. doi:10.7759/cureus.31641
   PubMed Web of Science ®Google Scholar
• Abdullah I, Bdaiwi AS, Wess M, Camferdam RR. Atypical case of schmidt’s syndrome in a young male. Cureus. 2022;14(6):e26322. doi:10.7759/cureus.26322
   PubMed Web of Science ®Google Scholar
• Murphy SA, Mohd Din FH, O’Grady MJ. Adolescent onset of autoimmune polyglandular syndrome type 2. BMJ Case Rep. 2022;15(5):e249839. doi:10.1136/bcr-2022-249839
   PubMedGoogle Scholar
• Bakkour A, Zakkor MD, Taha Khairy L, Horo R, Mohammed Sharif Ahmed E, Alhussein H. Autoimmune polyglandular syndrome type 2: a case report. Ann Med Surg. 2022;78:103742. doi:10.1016/j.amsu.2022.103742
   PubMed Web of Science ®Google Scholar
• Tenório JR, Tuma MM, Andrade NS, Santana T, Gallottini M. Oral manifestations of autoimmune polyglandular syndrome type 1. Spec Care Dentist. 2022;42(5):531–535. doi:10.1111/scd.12703
   PubMed Web of Science ®Google Scholar
• Rushworth RL, Chrisp GL, Bownes S, Torpy DJ, Falhammar H. Adrenal crises in adolescents and young adults. Endocrine. 2022;77(1):1–10. doi:10.1007/s12020-022-03070-3
   PubMed Web of Science ®Google Scholar
• Silajdzija E, Bliddal S, Borgwardt L, et al. Severe weight loss in a hypothyroid patient as an acute presentation of autoimmune polyglandular syndrome type II. Hormones. 2022;21(2):317–322. doi:10.1007/s42000-021-00344-9
   PubMedGoogle Scholar
• Graf S, Poeppelman RS, McVean J, Rayannavar A, Sunni M. An unusual presentation of primary adrenal insufficiency with new onset type 1 diabetes: case report and review of the literature. J Pediatr Endocrinol Metab. 2021;35(4):531–534. doi:10.1515/jpem-2021-0193
   PubMed Web of Science ®Google Scholar
• Chrisp GL, Quartararo M, Torpy DJ, Falhammar H, Rushworth RL. Trends in hospital admissions for adrenal insufficiency in adolescents and young adults in the 21st century. Front Endocrinol. 2022;13:986342. doi:10.3389/fendo.2022.986342
   PubMed Web of Science ®Google Scholar
• Rafique M, Das D. Successful pregnancy outcome in a lady with polyglandular autoimmune syndrome type II. J Coll Physicians Surg Pak. 2022;32(1):102–104. doi:10.29271/jcpsp.2022.01.102
   PubMed Web of Science ®Google Scholar
• Laakso S, Holopainen E, Betterle C, et al. Pregnancy outcome in women with APECED (APS-1): a multicenter study on 43 females with 83 pregnancies. J Clin Endocrinol Metab. 2022;107(2):e528–e537. doi:10.1210/clinem/dgab705
   PubMed Web of Science ®Google Scholar
• Gonciarz M, Krogulecki M, Brodowska-Kania D, Cierniak S, Kamiński G. Delay in diagnosis of autoimmune polyendocrine syndrome type 2 as a consequence of misinterpretation of gastrointestinal symptoms. Case Rep Gastrointest Med. 2022;2022:6623020. doi:10.1155/2022/6623020
   PubMed Web of Science ®Google Scholar
• Pinheiro RL, Pinheiro SL, Nunes Silva T, et al. Ocular sarcoidosis and autoimmune polyglandular syndrome type 2: a case report. Ocul Immunol Inflamm. 2022;1–4. doi:10.1080/09273948.2022.2122513
   PubMed Web of Science ®Google Scholar
• Batta A, Gupta AK, Singal G, et al. Autoimmune polyendocrine syndrome II presenting paradoxically as Takotsubo cardiomyopathy: a case report and reappraisal of pathophysiology. Egypt Heart J. 2022;74(1):82. doi:10.1186/s43044-022-00321-6
   PubMedGoogle Scholar
• Bapat P, Kushwaha S, Gupta C, Kirangowda R, Seth V. Autoimmune polyglandular syndrome type II presenting as subacute combined degeneration of spinal cord: a neuroendocrinology crossroad. Rom J Intern Med. 2022;60(2):123–126. doi:10.2478/rjim-2021-0038
   PubMed Web of Science ®Google Scholar
• Ismaeel H, Tariq S, Akram Z. End-stage renal disease in a patient with schmidt’s syndrome: a case report. Cureus. 2022;14(7):e27342. doi:10.7759/cureus.27342
   PubMed Web of Science ®Google Scholar
• Park E, Kim MS, Noh ES, et al. Multiple endocrine neoplasia type 2 and autoimmune polyendocrine syndromes (type 1 diabetes mellitus and Graves’ disease) in a 16-year-old male with Kabuki syndrome. Endocr J. 2022;69(10):1211–1216. doi:10.1507/endocrj.EJ22-0084
   PubMed Web of Science ®Google Scholar
• Zhu H, Yu GY. Lacrimo-auriculo-dento-digital syndrome with AIRE mutation: a case report. J Stomatol Oral Maxillofac Surg. 2022;123(6):e988–e990. doi:10.1016/j.jormas.2022.07.014
   PubMed Web of Science ®Google Scholar
• Qian G, Yan X, Xuan J, Zheng D, He Z, Shen J. A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1. Front Cell Dev Biol. 2022;10:948350. doi:10.3389/fcell.2022.948350
   PubMed Web of Science ®Google Scholar
• Skrabic V, Skrabic I, Skrabic R, Roje B, Simunovic M. Clinical characteristics in the longitudinal follow-up of APECED syndrome in Southern Croatia-case series. Genes. 2022;13(4):558. doi:10.3390/genes13040558
   PubMed Web of Science ®Google Scholar
• Setoodeh A, Panjeh-Shahi S, Bahmani F, et al. Molecular and clinical characterization of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) in Iranian non-Jewish patients: report of two novel AIRE gene pathogenic variants. Orphanet J Rare Dis. 2022;17(1):10. doi:10.1186/s13023-021-02170-z
   PubMed Web of Science ®Google Scholar
• Culp CJ, Pappas CM, Toso M, Qu P, Mamalis N, Hageman GS. Clinical, histological and genetic findings in a donor with a clinical history of type 1 autoimmune polyendocrinopathy syndrome. Am J Ophthalmol Case Rep. 2022;25:101266. doi:10.1016/j.ajoc.2022.101266
   PubMedGoogle Scholar
• Özer Y, Turan H, Dağdeviren Çakır A, et al. Left ventricular systolic dysfunction related to adrenal insufficiency in a case due to autoimmune polyendocrine syndrome type 1 with a novel variant. Mol Syndromol. 2023;14(1):65–70. doi:10.1159/000526221
   PubMed Web of Science ®Google Scholar
• Bouça B, Nogueira A, Caetano J, Cardoso R, Dinis I, Mirante A. Clinical characteristics of polyglandular autoimmune syndromes in pediatric age: an observational study. J Pediatr Endocrinol Metab. 2022;35(4):477–480. doi:10.1515/jpem-2022-0050
   PubMed Web of Science ®Google Scholar
• Fichna M, Małecki PP, Gębarski B, Gębarska H, Ruchała M. Aggregation of autoimmunity in extended families of people with autoimmune Addison disease. Intern Med J. 2022;52(7):1225–1231. doi:10.1111/imj.15337
   PubMed Web of Science ®Google Scholar
• Sjøgren T, Bratland E, Røyrvik EC, et al. Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies. J Autoimmun. 2022;133:102917. doi:10.1016/j.jaut.2022.102917
   PubMed Web of Science ®Google Scholar
• Meling Stokland AE, Ueland G, Lima K, et al. Autoimmune thyroid disorders in autoimmune addison disease. J Clin Endocrinol Metab. 2022;107(6):e2331–e2338. doi:10.1210/clinem/dgac089
   PubMed Web of Science ®Google Scholar
• Mahbuba S, Mohsin F, Islam N, et al. Clinical presentations of acquired hypothyroidism in children: experience in a tertiary care hospital in Bangladesh. Mymensingh Med J. 2022;31(4):1077–1083.
   PubMedGoogle Scholar
• Sheklabadi E, Sharifi Y, Tabarraee M, Tamehrizadeh SS, Rabiee P, Hadaegh F. Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review. Thromb J. 2022;20(1):39. doi:10.1186/s12959-022-00397-9
   PubMed Web of Science ®Google Scholar
• Tan JW, Shukla A, Hu JR, Majumdar SK. Spontaneous adrenal hemorrhage with mild hypoadrenalism in a patient anticoagulated with apixaban for antiphospholipid syndrome: a case report and literature review. Case Rep Endocrinol. 2022;2022:6538800. doi:10.1155/2022/6538800
   PubMed Web of Science ®Google Scholar
• Machado IFR, Menezes IQ, Figueiredo SR, et al. Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report. J Clin Endocrinol Metab. 2022;107(1):e394–e400. doi:10.1210/clinem/dgab557
   PubMed Web of Science ®Google Scholar
• Szwarcbard N, Davis A, Bach LA, Hackman K. Adrenal gland haemorrhages following motor vehicle accident with resultant adrenal insufficiency. Endocrinol Diabetes Metab Case Rep. 2022;2022:21–0208. doi:10.1530/EDM-21-0208
   PubMedGoogle Scholar
• Khakwani AS, Waqar F, Khan UA, Anwar MN. A case of bilateral adrenal hemorrhage: the exceptional cause of adrenal insufficiency. Cureus. 2022;14(3):e23413. doi:10.7759/cureus.23413
   PubMed Web of Science ®Google Scholar
• Kalinoski T. Waterhouse-friderichsen syndrome with bilateral adrenal hemorrhage associated with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in an adult patient with history of intravenous drug use. Am J Case Rep. 2022;23:e936096. doi:10.12659/AJCR.936096
   PubMed Web of Science ®Google Scholar
• Shalit A, Sarantis P, Koustas E, Trifylli EM, Matthaios D, Karamouzis MV. Predictive biomarkers for immune-related endocrinopathies following immune checkpoint inhibitors treatment. Cancers. 2023;15(2):375. doi:10.3390/cancers15020375
   PubMed Web of Science ®Google Scholar
• Barnabei A, Senes P, Scoppola A, et al. Endocrine toxicities of antineoplastic therapy: the adrenal topic. Cancers. 2022;14(3):593. doi:10.3390/cancers14030593
   PubMed Web of Science ®Google Scholar
• Druce I, Tawagi K, Shaw JLV, Ibrahim A, Lochnan H, Ong M. Routine screening for central and primary adrenal insufficiency during immune-checkpoint inhibitor therapy: an endocrinology perspective for oncologists. Curr Oncol. 2022;29(7):4665–4677. doi:10.3390/curroncol29070370
   PubMed Web of Science ®Google Scholar
• Adams S, Othus M, Patel SP, et al. A multicenter phase II trial of ipilimumab and nivolumab in unresectable or metastatic metaplastic breast cancer: cohort 36 of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART, SWOG S1609). Clin Cancer Res. 2022;28(2):271–278. doi:10.1158/1078-0432.CCR-21-2182
   PubMed Web of Science ®Google Scholar
• Schoenfeld JD, Giobbie-Hurder A, Ranasinghe S, et al. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, Phase 2 trial. Lancet Oncol. 2022;23(2):279–291. doi:10.1016/S1470-2045(21)00658-6
   PubMed Web of Science ®Google Scholar
• Tykodi SS, Gordan LN, Alter RS, et al. Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial. J Immunother Cancer. 2022;10(2):e003844. doi:10.1136/jitc-2021-003844
   PubMed Web of Science ®Google Scholar
• Schonfeld SJ, Tucker MA, Engels EA, et al. Immune-related adverse events after immune checkpoint inhibitors for melanoma among older adults. JAMA Netw Open. 2022;5(3):e223461. doi:10.1001/jamanetworkopen.2022.3461
   PubMed Web of Science ®Google Scholar
• Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X. Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS. J Endocrinol Invest. 2022;45(11):2131–2137. doi:10.1007/s40618-022-01845-z
   PubMed Web of Science ®Google Scholar
• Galliazzo S, Morando F, Sartorato P, Bortolin M, De Menis E. A case of cancer-associated hyponatraemia: primary adrenal insufficiency secondary to nivolumab. Endocr Metab Immune Disord Drug Targets. 2022;22(3):363–366. doi:10.2174/1871530321666210708142815
   PubMed Web of Science ®Google Scholar
• Cui K, Wang Z, Zhang Q, Zhang X. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study. Ann Transl Med. 2022;10(5):251. doi:10.21037/atm-21-7006
   PubMed Web of Science ®Google Scholar
• Yuen KCJ, Samson SL, Bancos I, et al. American Association of Clinical Endocrinology Disease State Clinical Review: evaluation and management of immune checkpoint inhibitor-mediated endocrinopathies: a practical case-based clinical approach. Endocr Pract. 2022;28(7):719–731. doi:10.1016/j.eprac.2022.04.010
   PubMed Web of Science ®Google Scholar
• Monti S, Presciuttini F, Deiana MG, et al. Cortisol deficiency in lenvatinib treatment of thyroid cancer: an underestimated common adverse event. Thyroid. 2022;32(1):46–53. doi:10.1089/thy.2021.0040
   PubMed Web of Science ®Google Scholar
• Freyer CW, Loren AW. Fluconazole-induced adrenal insufficiency following allogeneic hematopoietic cell transplant. J Oncol Pharm Pract. 2022;28(8):1922–1925. doi:10.1177/10781552221087902
   PubMed Web of Science ®Google Scholar
• Sabbadin C, Betterle C, Scaroni C, Ceccato F. Frequently asked questions in patients with adrenal insufficiency in the time of COVID-19. Front Endocrinol. 2021;12:805647. doi:10.3389/fendo.2021.805647
   PubMed Web of Science ®Google Scholar
• Lisco G, De Tullio A, Stragapede A, et al. COVID-19 and the endocrine system: a comprehensive review on the theme. J Clin Med. 2021;10(13):2920. doi:10.3390/jcm10132920
   PubMed Web of Science ®Google Scholar
• Eguchi E. Post-COVID-19 syndrome increased the requirement for corticosteroids in a dialysis patient with preexisting adrenal insufficiency. CEN Case Rep. 2023;1–5. doi:10.1007/s13730-023-00772-z
   PubMed Web of Science ®Google Scholar
• Tremblay ES. Commentary on an unusual presentation of autoimmune primary adrenal insufficiency. Clin Chem. 2022;68(11):1380. doi:10.1093/clinchem/hvac163
   PubMedGoogle Scholar
• Sánchez J, Cohen M, Zapater JL, Eisenberg Y. Primary adrenal insufficiency after COVID-19 infection. AACE Clin Case Rep. 2022;8(2):51–53. doi:10.1016/j.aace.2021.11.001
   PubMedGoogle Scholar
• Eskandari D, Ziaee A, Amirfarhangi Anbardan A, Zeinali E, Tirkan A. Primary adrenal insufficiency and myocarditis in COVID-19 disease: a case report. BMC Endocr Disord. 2022;22(1):336. doi:10.1186/s12902-022-01257-3
   PubMed Web of Science ®Google Scholar
• Beshay L, Wei K, Yang Q. Newly diagnosed autoimmune Addison’s disease in a patient with COVID-19 with autoimmune disseminated encephalomyelitis. BMJ Case Rep. 2022;15(12):e250749. doi:10.1136/bcr-2022-250749
   PubMedGoogle Scholar
• Azmoodeh E, Kheirieh A, Mahdavi S, Toufan F, Nazemi S. The first report of a known 4A syndrome patient with suspected manifestations of COVID-19, what was the final outcome? Heliyon. 2022;8(12):e11766. doi:10.1016/j.heliyon.2022.e11766
   PubMed Web of Science ®Google Scholar
• Gaber CE, Cotton CC, Eluri S, Lund JL, Farrell TM, Dellon ES. Autoimmune and viral risk factors are associated with achalasia: a case-control study. Neurogastroenterol Motil. 2022;34(7):e14312. doi:10.1111/nmo.14312
   PubMed Web of Science ®Google Scholar
• Suryadevara V, Merugu C, Perumal NL, Sahoo J, Kamalanathan S, Naik D. Adrenal crisis in a patient with APS2 due to COVID-19: a case report. J Family Med Prim Care. 2022;11(5):2228–2230. doi:10.4103/jfmpc.jfmpc_1405_21
   PubMedGoogle Scholar
• Flokas ME, Bustamante VH, Kanakatti Shankar R. New-onset primary adrenal insufficiency and autoimmune hypothyroidism in a pediatric patient presenting with MIS-C. Horm Res Paediatr. 2022;95(4):397–401. doi:10.1159/000525227
   PubMed Web of Science ®Google Scholar
• Bozkur E, Turgut S, Pamuk N, et al. The effect of COVID-19 process on patients with endocrinological disease in a pandemic hospital: what happened to the others? Arch Endocrinol Metab. 2023;67(1):45–54. doi:10.20945/2359-3997000000525
   PubMed Web of Science ®Google Scholar
• Pilli T, Dalmiglio C, Dalmazio G, et al. No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine. Eur J Endocrinol. 2022;187(1):K7–K11. doi:10.1530/EJE-21-1236
   PubMed Web of Science ®Google Scholar